Mobile Site ›
Print Friendly View

Test ID: PMLR    
PML/RARA Quantitative, PCR

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.

Yes

Useful For Suggests clinical disorders or settings where the test may be helpful

Diagnosis of acute promyelocytic leukemia (APL)

 

Detection of residual or recurrent APL

 

Monitoring the level of promyelocytic leukemia/retinoic acid receptor alpha (PML/RARA) in APL patients

Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.

See Acute Promyelocytic Leukemia: Guideline to Diagnosis and Follow-up in Special Instructions.

Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test

Method Name A short description of the method used to perform the test

Quantitative, Real-Time Polymerase Chain Reaction (PCR)
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)         

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

PML/RARA Quantitative, PCR

Aliases Lists additional common names for a test, as an aid in searching

(15;17)(q22;q12)
Acute myeloid leukemia (AML)
Acute promyelocytic leukemia (APL)
AML (acute myeloid leukemia)
AMPL
APL minimum residual disease
PCR
PML/RARA